Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2000;84:129-133; doi:10.1136/heart.84.2.129
Copyright © 2000 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2000;84:129-133 ( August )

Viewpoint

Clinical trials in cardiovascular medicine: are we looking for statistical significance or clinical relevance?

R Willenheimera, B Dahlöfb, A Gordonc

a Department of Cardiology, Malmö University Hospital, S-20502 Malmö, Sweden, b Clinical Research Institute, Göteborg University, Göteborg, Sweden, c Department of Cardiology, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden

Correspondence to: Dr Willenheimer email: ronnie.willenheimer@medforsk.mas.lu.se

The first 150 words of the full text of this article appear below.

    Introduction

During the last two decades several large clinical trials have documented beneficial effects of different pharmacological interventions on morbidity and mortality in various cardiovascular conditions. Based on the results of these trials physicians in general feel convinced that there is a considerable reduction of mortality and morbidity as a result of treatment with: (a) beta  receptor blockers in patients with acute myocardial infarction as well as in the postinfarction period; (b) acetylsalicylic acid (ASA; aspirin) and thrombolytic drugs in patients with acute myocardial infarction; (c) angiotensin converting enzyme (ACE) inhibitors in patients with left ventricular systolic dysfunction irrespective of symptoms of heart failure and, as recently shown in the HOPE study, in patients with high cardiovascular risk but without heart failure or obvious left ventricular systolic dysfunction; (d) beta  receptor blockers and spironolactone in addition to an ACE inhibitor in patients with chronic heart failure; (e) diuretics, beta  receptor blockers, calcium channel blockers, . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Hutcheon, S D, Gillespie, N D, Crombie, I K, Struthers, A D, McMurdo, M E T (2002). Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial. Heart 88: 373-377 [Abstract] [Full Text]  

eLetters:

Read all eLetters

Application of clinical trial results
Pitt O Lim
Online, 9 Aug 2000 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.